Correlation between liver fibrosis in non-alcoholic fatty liver disease and insulin resistance indicators: a cross-sectional study from NHANES 2017–2020

Correlation between liver fibrosis in non-alcoholic fatty liver disease and insulin resistance indicators: a cross-sectional study from NHANES 2017–2020

IntroductionNon-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease worldwide, with liver fibrosis (LF) being a crucial pathological feature in the progression of NAFLD. Insulin resistance (IR) is believed to play an important role in the pathogenesis of NAFLD and the d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bo Yang, Mingsu Gong, Xiaojie Zhu, Yang Luo, Ruiqiu Li, Hai Meng, Yuhan Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Endocrinology
Subjects:	non-alcoholic fatty liver disease liver fibrosis insulin resistance logistic regression TyG-WHtR
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1514093/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of the triglyceride glucose index with obesity indicators and hypertension in American adults based on NHANES 2013 to 2018
by: Pingping Huang, et al.
Published: (2025-01-01)

Association between TyG related parameters and metabolic dysfunction associated fatty liver disease among nondiabetic individuals
by: Qian Zhang, et al.
Published: (2025-02-01)

Association between the triglyceride glucose body mass index and asthma: evidence from NHANES 2011–2018
by: Sijia Yu, et al.
Published: (2025-01-01)

Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver Recipients
by: R. M. Kurabekova, et al.
Published: (2020-09-01)

Association of triglyceride-glucose-body mass index with all-cause mortality among individuals with cardiovascular disease: results from NHANES
by: Yiaoran Sun, et al.
Published: (2025-01-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Quantitative ultrasound rating of liver fibrosis in children with cystic fibrosis
by: G. M. Dvoryakovskaya, et al.
Published: (2014-08-01)

Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease
by: Yang Wang, et al.
Published: (2024-04-01)

Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
by: Zhifeng Gao, et al.
Published: (2025-01-01)

Prevalence and risk factors of liver fibrosis in patients with metabolic-associated fatty liver disease undergoing bariatric surgery
by: Amr Elsayed, et al.
Published: (2024-12-01)

The role of the interleukin family in liver fibrosis
by: Zixin Zhang, et al.
Published: (2025-02-01)

Association between non-insulin-based insulin resistance surrogate makers and Helicobacter pylori infection: a population-based study
by: Jiayu Qiu, et al.
Published: (2025-01-01)

Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
by: V. T. Ivashkin, et al.
Published: (2022-12-01)

Non-invasive of liver fibrosis diagnostics: the role of serum markers
by: A. F. Sheptulina, et al.
Published: (2015-05-01)

Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018
by: Bin Liang, et al.
Published: (2025-02-01)

Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
by: Antonio Liguori, et al.
Published: (2025-01-01)

Protective role of ginsenoside Rg1 in the dynamic progression of liver injury to fibrosis: a preclinical meta-analysis
by: Lijuan Dan, et al.
Published: (2025-01-01)

Association between mixed exposure of non-persistent pesticides and liver fibrosis in the general US population: NHANES 2013–2016
by: Shuge Shu, et al.
Published: (2025-01-01)

Gene therapy by hepatocyte growth factor results in regression of experimental liver fibrosis
by: N. A. Dzhoyashvili, et al.
Published: (2010-08-01)

Collagen fibers quantification for liver fibrosis assessment using linear dichroism photoacoustic microscopy
by: Yang Qiu, et al.
Published: (2025-04-01)

Association of the triglyceride glucose index with all cause and CVD mortality in the adults with diabetes aged < 65 years without cardiovascular disease
by: Chang Liu, et al.
Published: (2025-01-01)

Large annotated ultrasound dataset of non-alcoholic fatty liver from Saudi hospitals for analysis and applicationsOpen Science framework or (OSF)
by: Fahad Alshagathrh, et al.
Published: (2025-02-01)

Liver macrophage-derived exosomal miRNA-342-3p promotes liver fibrosis by inhibiting HPCAL1 in stellate cells
by: Wenshuai Li, et al.
Published: (2025-02-01)

Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients
by: Qiyao Wei, et al.
Published: (2025-02-01)

Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
by: I. A. Goncharova, et al.
Published: (2023-03-01)

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota
by: R. V. Maslennikov, et al.
Published: (2018-09-01)

Association Between Liver Fibrosis and Risk of Incident Stroke and Mortality: A Large Prospective Cohort Study
by: Zijie Wang, et al.
Published: (2025-02-01)

The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease
by: T. S. Krolevets, et al.
Published: (2020-12-01)

The N‐terminal domain of gasdermin D induces liver fibrosis by reprogrammed lipid metabolism
by: Xue Wang, et al.
Published: (2025-01-01)

Cellular and immune landscape of chronic liver diseases: insights from immunophenotyping
by: Shaghayegh Soleimani, et al.
Published: (2025-01-01)

Triglyceride glucose-waist circumference as a useful predictor for diabetes mellitus: a secondary retrospective analysis utilizing a Japanese cohort study
by: Yawei Li, et al.
Published: (2025-01-01)

A machine learning based algorithm accurately stages liver disease by quantification of arteries
by: Zhengxin Li, et al.
Published: (2025-01-01)

Serum chemerin level in patients with liver cirrhosis and primary and multifocal hepatocellular carcinoma with consideration of insulin level
by: Monika Pazgan-Simon, et al.
Published: (2024-10-01)

High triglyceride-glucose index in patients with diabetes mellitus is associated with an increased likelihood of nephropathy development: evidence from a meta-analysis among Asian population
by: Raphael Enrique Tiongco, et al.
Published: (2025-01-01)

Mathematical modeling of liver fibrosis
by: Avner Friedman, et al.
Published: (2017-01-01)

Association of dietary quality and mortality in the non-alcoholic fatty liver disease and advanced fibrosis populations: NHANES 2005–2018
by: Xingyong Huang, et al.
Published: (2025-01-01)

Amelioration of liver fibrosis with autologous macrophages induced by IL-34-based condition
by: Yuichi Igarashi, et al.
Published: (2025-01-01)

The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease
by: Sun Xin, et al.
Published: (2017-03-01)

Evaluation of liver fibrosis in HCV-infected patients using two-dimensional shear-wave elastography (2D-SWE) before and after antiviral treatment
by: Inglot Marcin, et al.
Published: (2024-12-01)